← Back to Search

Escape for Smoking

N/A

Waitlist Available

Led By Mary E. Cooley, PhD

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial is testing the ESCAPE program to see if it can help women with HIV quit smoking and improve their lung health.

Who is the study for?

This trial is for high-risk smokers aged 55-77 who smoke at least 5 cigarettes a day and have a history of heavy smoking (≥30 pack years). Participants must be English-speaking, own a mobile phone with video call capability, have active health insurance, and can complete an interview. They should not have had lung cancer or low-dose CT screening before.Check my eligibility

What is being tested?

The study compares the ESCAPE program—a smoking cessation approach that includes education on lung screening—to standard care. The goal is to see if adding lung screening information helps people quit smoking more effectively and improves their overall lung health.See study design

What are the potential side effects?

Since this trial focuses on behavioral intervention rather than medication, traditional side effects are not expected. However, participants may experience stress or anxiety related to quitting smoking or from changes in behavior due to the program.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

7-day point prevalence smoking cessation rate

Malignant Neoplasms

number of cigarettes smoked/day

Secondary outcome measures

Completion rate

Narrative Engagement Scale scores

Percentage of the group indicate that the film would have value to others

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Standard CareExperimental Treatment1 Intervention

The usual care program will include 1 counseling session, nicotine replacement therapy at no cost referral and enrollment in quitworks and an educational brochure about lung cancer screening

Group II: EscapeExperimental Treatment1 Intervention

The ESCAPE program provides 8 counseling sessions over the phone, provides nicotine replacement therapy at no cost, and education about lung screening

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor

1,079 Previous Clinical Trials

340,833 Total Patients Enrolled

American Association for Cancer ResearchOTHER

8 Previous Clinical Trials

669 Total Patients Enrolled

Mary E. Cooley, PhDPrincipal Investigator - Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1 Previous Clinical Trials

179 Total Patients Enrolled

Media Library

ESCAPE Clinical Trial Eligibility Overview. Trial Name: NCT04691297 — N/A

Tobacco Smoking Research Study Groups: Standard Care, Escape

Tobacco Smoking Clinical Trial 2023: ESCAPE Highlights & Side Effects. Trial Name: NCT04691297 — N/A

ESCAPE 2023 Treatment Timeline for Medical Study. Trial Name: NCT04691297 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What objective is this research endeavor attempting to accomplish?

"The primary purpose of this 6-month long study is to track the average number of cigarettes smoked per day by participants. Additionally, researchers will be scoring completion rates (i.e., percentage of videos watched), narrative engagement scores on a scale from 1-7, and polygenic risk score based on genetic variants associated with smoking status in adults."

Answered by AI

Does this trial include adults over 25 years old?

"The age restriction for this medical trial mandates that participants are between 55 and 77 years old."

Answered by AI

Does my medical history make me a suitable participant in this experiment?

"This clinical trial will admit 153 individuals aged 55 to 77 with notable smoking habits. To be eligible, further requirements must also be fulfilled such as possessing an ECOG performance level below 2 and having a minimum of 30 pack years in terms of smoking history. Moreover, it is important that participants possess a mobile phone capable of video calls which has not been used for any prior lung cancer screening tests; they should have active health insurance along with contact information regarding their primary care provider (PCP)."

Answered by AI

Are there any vacancies in this clinical experimentation available to participants?

"This clinical trial, first posted on February 1st 2021 and last edited August 22nd 2022 is not actively enrolling. Nevertheless, there are over 1700 other studies currently recruiting participants as listed on clinicaltrials.gov."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Digitally Enhanced Smoking Cessation for High Risk Smokers

Mary E. Cooley, Phd 2021. "Digitally Enhanced Smoking Cessation for High Risk Smokers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04691297.

All > Lung Cancer Boston > Smoking Cessation